On Tuesday, Axsome Therapeutics Inc (NASDAQ: AXSM) opened lower -6.50% from the last session, before settling in for the closing price of $109.68. Price fluctuations for AXSM have ranged from $72.21 to $139.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -24.44% over the past five years. Company’s average yearly earnings per share was noted 40.71% at the time writing. With a float of $40.44 million, this company’s outstanding shares have now reached $49.22 million.
Let’s look at the performance matrix of the company that is accounted for 683 employees. In terms of profitability, gross margin is 91.49%, operating margin of -62.54%, and the pretax margin is -64.37%.
Axsome Therapeutics Inc (AXSM) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Axsome Therapeutics Inc is 17.86%, while institutional ownership is 74.78%. The most recent insider transaction that took place on Jun 20 ’25, was worth 768,525. In this transaction General Counsel of this company sold 7,500 shares at a rate of $102.47, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 23 ’25, when Company’s General Counsel sold 6,014 for $100.12, making the entire transaction worth $602,122. This insider now owns 0 shares in total.
Axsome Therapeutics Inc (AXSM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 40.71% per share during the next fiscal year.
Axsome Therapeutics Inc (NASDAQ: AXSM) Trading Performance Indicators
Check out the current performance indicators for Axsome Therapeutics Inc (AXSM). In the past quarter, the stock posted a quick ratio of 1.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.77, a number that is poised to hit -1.07 in the next quarter and is forecasted to reach 1.37 in one year’s time.
Technical Analysis of Axsome Therapeutics Inc (AXSM)
Axsome Therapeutics Inc (NASDAQ: AXSM) saw its 5-day average volume 0.62 million, a negative change from its year-to-date volume of 0.8 million. As of the previous 9 days, the stock’s Stochastic %D was 27.81%.
During the past 100 days, Axsome Therapeutics Inc’s (AXSM) raw stochastic average was set at 36.01%, which indicates a significant increase from 2.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.85 in the past 14 days, which was lower than the 3.93 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $106.69, while its 200-day Moving Average is $104.13. Nevertheless, the first resistance level for the watch stands at $107.65 in the near term. At $112.74, the stock is likely to face the second major resistance level. The third major resistance level sits at $115.30. If the price goes on to break the first support level at $100.00, it is likely to go to the next support level at $97.44. Assuming the price breaks the second support level, the third support level stands at $92.35.
Axsome Therapeutics Inc (NASDAQ: AXSM) Key Stats
There are currently 49,236K shares outstanding in the company with a market cap of 5.05 billion. Presently, the company’s annual sales total 385,690 K according to its annual income of -287,220 K. Last quarter, the company’s sales amounted to 121,460 K and its income totaled -59,410 K.
